Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine p...
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
About this item
Full title
Author / Creator
Hata, Taishi , Uemura, Mamoru , Danno, Katsuki , Yoshioka, Shinichi , Matsuda, Chu , Kagawa, Yoshinori , Shingai, Tatsushi , Suzuki, Yozo , Tei, Mitsuyoshi , Tanida, Tsukasa , Komori, Takamichi , Okamura, Shu , Ota, Hirofumi , Takemoto, Hiroyoshi , Ogino, Takayuki , Miyoshi, Norikatsu , Yamamoto, Hirofumi , Murata, Kohei , Doki, Yuichiro and Eguchi, Hidetoshi
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Adjuvant oxaliplatin plus capecitabine (XELOX) therapy is recommended for patients with curatively resected colon cancer. However, prospective data on its practical application in Japanese patients are limited. Therefore, we aimed to conduct a long-term clinical evaluation of the efficacy and safety of adjuvant XELOX in patients with curatively res...
Alternative Titles
Full title
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
Authors, Artists and Contributors
Author / Creator
Uemura, Mamoru
Danno, Katsuki
Yoshioka, Shinichi
Matsuda, Chu
Kagawa, Yoshinori
Shingai, Tatsushi
Suzuki, Yozo
Tei, Mitsuyoshi
Tanida, Tsukasa
Komori, Takamichi
Okamura, Shu
Ota, Hirofumi
Takemoto, Hiroyoshi
Ogino, Takayuki
Miyoshi, Norikatsu
Yamamoto, Hirofumi
Murata, Kohei
Doki, Yuichiro
Eguchi, Hidetoshi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8397edc0e89c4d1c838969c4c7173351
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8397edc0e89c4d1c838969c4c7173351
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-73222-0
